← Eichor
Study identifier: NCT06666049 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist (Multicentric)

Condition: Aspiration Pneumonia  ·  Sponsor: Clinica Universidad de Navarra, Universidad de Navarra

PhaseN/A
Planned participants39
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersNo

About this study

1\. Introduction Scheduled surgery requires patients to undergo a preoperative fasting period of at least 6 hours to reduce the risk of perioperative pulmonary aspiration. However, certain medications and conditions may delay gastric emptying, potentially increasing aspiration risk. These include diabetic gastroparesis and the use of glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of diabetes and obesity. GLP-1 receptor agonists are widely used due to their beneficial effects on glycemic control and weight reduction. However, one of their known effects is delayed gastric emptying, which may result in increased residual gastric content despite adherence to standard fasting guidelines. Recent reports have described cases of pulmonary aspiration during anesthesia in patients receiving GLP-1 receptor agonists, even after appropriate fasting. Given the increasing use of these medications, there is a need for objective assessment tools to evaluate gastric content in the perioperative setting. Gastric ultrasonography has emerged as a non-invasive bedside technique that may help identify patients at increased risk of aspiration and guide airway management strategies.

This description comes directly from the study's public registry record.

Talk to the study team

Carlos Puga Carrasco, MD  ·  0034913531920  ·  cpuga@unav.es

Miguel Angel Fernandez-Vaquero, MD,PhD  ·  0034913531920  ·  mferva7@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Clinica Universidad NavarraMadrid, Madrid, SpainRecruiting
CAUSA SalamancaSalamanca, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06666049